Sign in
CompletedNo phase

Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy

Key facts

Who runs it
Services Hospital, Lahore
Where
Pakistan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
136 people enrolled
Started
10 Jan 2022
Ended
20 Jan 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Intraoperative topical methylene blue spray
  • Conventional Dissection
Record updated
9 February 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • benign multinodular goiter scheduled for thyroidectomy

Who cannot take part

  • Recurrent/metastatic disease
  • Methylene blue allergy
  • Hepatic/renal impairment
  • Preoperative vocal cord dysfunction
  • Coagulopathy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized controlled trial aims to evaluate the efficacy of intraoperative methylene blue (MB) spray in improving the identification and preservation of the recurrent laryngeal nerve (RLN) and parathyroid glands (PGs) during thyroidectomy. The study compares outcomes between patients receiving topical MB spray and those undergoing conventional visual dissection alone. Primary outcomes include the incidence of RLN injury and postoperative serum calcium levels.

The 2 groups in the trial

  • Methylene Blue labellingTreatment being tested

    Treatment: Intraoperative topical methylene blue spray

  • Conventional DissectionExisting treatment, for comparison

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy: A Randomized Controlled Trial
Record updated
9 February 2026